Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
about
High throughput screening for small molecule enhancers of the interferon signaling pathway to drive next-generation antiviral drug discoveryConvergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.5,6-Dimethylxanthenone-4-acetic acid (DMXAA) activates stimulator of interferon gene (STING)-dependent innate immune pathways and is regulated by mitochondrial membrane potentialThe chemotherapeutic agent DMXAA as a unique IRF3-dependent type-2 vaccine adjuvant.Activation of mitogen-activated protein kinases by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) plays an important role in macrophage stimulationPharmacologic activation of the innate immune system to prevent respiratory viral infections.Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in miceAdenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer.Using macrophage activation to augment immunotherapy of established tumours.Identification of human-selective analogues of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Refractoriness of interferon-beta signaling through NOD1 pathway in mouse respiratory epithelial cells using the anticancer xanthone compoundVadimezan: 2-(5,6-dimethyl-9-oxo-9H-xanthen-4-yl)acetic acid.Editorial: One small molecule: a new way to treat the flu?No difference in renal injury and fibrosis between wild-type and NOD1/NOD2 double knockout mice with chronic kidney disease induced by ureteral obstruction.
P2860
Q28483402-C921DFFE-1889-4502-B3AD-653AE7313B8FQ34150760-DD750C7A-3AC1-4E1E-924B-61CD657CD25FQ34303159-90657ADD-6352-4540-B738-D6E1AAAD7600Q34653072-69464E70-C3CD-4006-AFC7-EC6515F4EDD8Q35317995-5ECF62DF-8149-4506-A6BF-153589A17CB7Q35692082-2E4EEF65-7752-4078-B3A3-B511CA2AA739Q35961407-9784E3DF-0942-47C0-AC4E-678854D7C814Q36004154-8AEE3C72-4953-4DEB-9441-F8E790EE18C0Q36747346-68DF5547-E624-4922-A538-74EEF27BE0EBQ36747400-211A4D09-14FE-4AB5-A0A0-597903282B2FQ36839796-0AA96E54-0038-4D10-8ED3-2CE34A001BA1Q41366387-93CB4D51-F155-48A1-972A-EECDA809E9FBQ42609531-EB2FA5A9-CD25-4A2E-B70D-97914F96F192Q54967514-C4C83F81-6DF1-49AE-992C-4BCD702AE374
P2860
Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@ast
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
type
label
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@ast
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
prefLabel
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@ast
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
P2093
P2860
P356
P1476
Activation of the nucleotide o ...... one-4-acetic acid (Vadimezan).
@en
P2093
Guanjun Cheng
Lai-Ming Ching
Liang-Chuan S Wang
Steven M Albelda
Zvi G Fridlender
P2860
P304
10553-10562
P356
10.1074/JBC.M109.065631
P407
P577
2010-01-29T00:00:00Z